Cobblestone Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Cobblestone Asset Management's BMY Position: Q2 2026 in Review
Cobblestone Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q2 2026, selling an estimated $125K and leaving 12,772 shares worth $736K. The position accounts for 0.31% of the portfolio, ranked #46.
Cobblestone Asset Management first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.46M in Q1 2025. 943 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Cobblestone Asset Management held 12,772 shares of Bristol-Myers Squibb worth $736K as of Q2 2026.
- Cobblestone Asset Management sold 2,174 Bristol-Myers Squibb shares in Q2 2026, an estimated $125K.
- Bristol-Myers Squibb made up 0.31% of Cobblestone Asset Management's portfolio in Q2 2026, its #46 holding.
- Cobblestone Asset Management first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
- Cobblestone Asset Management's Bristol-Myers Squibb position peaked at $1.46M in Q1 2025.
- 943 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Cobblestone Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.